I've just read the Glaucus report. Well, all except the last few pages in Chinese. Very detailed, and, on the face of it, compelling. I would avoid this stock like the plague.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025